Helicobacter pylori eradication reduces microalbuminuria in type-2 diabetic patients: A prospective study

Acta Gastro-Enterologica Belgica

Volumn 77, Issue 2, 2014, Pages 235-239

  Yanik, Sinan ^a   Doǧan, Zeynal ^a   Sarikaya, Murat ^a   Ergul, Bilal ^a   Filik, Levent ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Diabetes; Endothelial dysfunction; H. pylori; Microalbuminuria

Indexed keywords

ANTIINFECTIVE AGENT; GLUCOSE; HEMOGLOBIN A1C;

ARTICLE; BACTERIAL CLEARANCE; CLINICAL TRIAL; COMPARATIVE STUDY; DIABETIC PATIENT; DISEASE CLEARANCE; DYSPEPSIA; GASTROINTESTINAL ENDOSCOPY; GLUCOSE BLOOD LEVEL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; RAPID UREASE TEST; UREA BREATH TEST; URINALYSIS;

ALBUMINURIA; DIABETES MELLITUS, TYPE 2; DYSPEPSIA; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 84905088174     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Park M.J., Cho I S.H., KIm D., Kang S.J., Chung S.J., Cho I S.Y., Yoon D.H., LIm S.H., KIm Y.S., YIm J.Y., KIm J.S., Jung H.C. Association between Helicobacter pylori seropositivity and the coronary artery calcium score in a screening population. Gut Liver, 2011, 5: 321-327.
2. JIa E.Z., Zhao F.J., Hao B., Zhu T.B., Wang L.S., Chen B., Cao K.J., Huang J., Ma W.Z., Yang Z.J., Zhang G. Helicobacter pylori infection is associated with decreased serum levels of high density lipoprotein, but not with the severity of coronary atherosclerosis. Lipids Health Dis., 2009, 8: 59.
3. KIm H.L., Jeon H.H., Park I.Y., Cho I J.M., Kang J.S., MIn K.W. Helicobacter pylori infection is associated with elevated low density lipoprotein cholesterol levels in elderly Koreans. J. Korean Med. Sci., 2011, 26: 654-658.
4. Gunj I T., Matsuhash I N., Sato H., Fuj Iba yash I K., Okumura M., Sasabe N., Urabe A. Helicobacter pylori infection significantly increases insulin resistance in the asymptomatic Japanese population. Helicobacter, 2009, 14: 144-150.
5. Polyzos S.A., Kountouras J., Zavos C., Deretz I G. The association between Helicobacter pylori infection and insulin resistance: a systematic review. Helicobacter, 2011, 16: 79-88.
6. Chung G.E., Heo N.J., Park M.J., Chung S.J., Kang H.Y., Kang S.J. Helicobacter pylori seropositivity in diabetic patients is associated with microalbuminuria. World J. Gastroenterol., 2013, 19: 97-102.
7. Nat Ional KIdne y Foundat Ion. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis., 2002, 39: S1-266.
8. Mogensen C.E., Chachat I A., Chr Istensen C.K., Close C.F., Deckert T., Hommel E., Kastrup J., Lefebvre P., Math Iesen E.R., Feldt-Rasmussen B. Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest., 1985, 9: 85-95.
9. Deckert T., Feldt-Rasmussen B., Borch-Jhonsen K., Jensen T., Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia, 1989, 32: 219-226.
10. Parv Ing H.H. Microalbuminuria in essential hypertension and diabetes mellitus. J. Hypertens Suppl., 1996, 14: 89-93.
11. KIlIç M., TaşkIn E., Sen Y., Dogan Y. Microalbuminuria in chronic hepatitis B infection. Indian Pediatr., 2010, 47: 511-515.
12. LIanqpunsakul S., Chalasan I N. Relationship between hepatitis C and microalbuminuria: results from the NHANES III. Kidney Int., 2005, 67: 285-290.
13. NIeto F.J., Folsom A.R., Sorl Ie P.D., Gra yston J.T., Wang S.P., Chambles L.E. Chalamydia infection and incident coronary heart disease: the Athereosclerosis Risk in Communities Study. Am. J. Epidemiol., 1999, 150: 149-156.
14. NIeto F.J., Adam E., Sorl Ie P., Farzadegan H., Meln Ick J.L., Comstock G.W., Szklo M. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation, 1996, 94: 922-927.
15. Hoffme Ister A., Rothenbacker D., Bode G., Persson K., Marz W., Nauck M.A., Brenner H., Hombach V., Koen Ig W. Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile. Arterioscler. Thromb. Vasc. Biol., 2001, 21: 427-432.
16. Ibrah Im A., Zaher T., Ghonemy T.A., El-AzIm S.A., El-AzIm M.A., Ramadan A. Impact of cytotoxin-associated gene A of Helicobacter pylori strains on microalbuminuria in type 2 diabetes. Saudi J. Kidney Dis. Transpl., 2010, 21: 694-700.
17. Tanriverd I O. Association of Helicobacter pylori infection with microalbuminuria in type 2 diabetic patients. Turk. J. Gastroenterol., 2011, 22: 569-574.
18. Gunj I T., Matsuhash I N., Sato H., Fuj Iba yash I K.I., Okumura M., Sasabe N., Urabe A. Helicobacter pylori infection is significantly associated with metabolic syndrome in the Japanese population. Am. J. Gastroenterol., 2009, 103: 3005-3010.
19. Prasad A., Zhu J., Halcox J.P., Waclaw Iw M.A., Epste In S.E., Quyyum I A.A. Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation, 2002, 106: 184-190.
20. Francesch I F., SEpulveda A.R., Gasbarr InI A., Pola P., SIlver I N.G., Gasbarr InI G., Graham D.Y., Genta R.M. Crossreactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis. Circulation, 2002, 106: 430-434.
21. Osh Ima T., Ozono R., Yano Y., OIsh I Y., Teragawa H., HIgash I Y., Yosh Izum I M., Kambe M. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J. Am. Coll. Cardiol., 2005, 45: 1219-1222.
22. Karolczak K., Olas B. Mechanism of action of homocysteine and its thiolactone in haemostasis system. Physiol. Res., 2009, 58: 623-633.
23. Evrengul H., Tanriverd I H., Kuru O., Enl I Y., Yuksel D., KIlIç A., Kaflan A., KIrac S., KIlIc M. Evelated homocysteine levels in patients with slow coronary flow: relationship with Helicobacter pylori infection. Helicobacter, 2007, 12: 298-305.
24. Tousoul Is D., Kampol I A.M., Tentolour Is C., Papageorg Iou N., Stefanad Is C. The role of nitric oxide on endothelial function. Curr. Vasc. Pharmacol., 2012, 10: 4-18.
25. Tob In N.P., Henehan G.T., Murphy R.P., Atherton J.C., GuInan A.F., Kerr Igan S.W., Cox D., Cah Ill P.A., Cumm Ins P.M. Helicobacter pylori-induced inhibition of vascular endothelial cell functions: a role for VacA-dependent nitric oxide reduction. Am. J. Physiol., 2008, 295: 1403-1413.
26. De Cosmo S., MInenna A., Ludov Ico O., Mastro Ianno S., DI GIorg Ia A., PIrro L., TrIsch Itta V. Increased urinary albumin excretion, insulin resistance, and related cardiovascular risk factors in patients with type 2 diabetes: evidence of a sex-specific association. Diabetes Care, 2005, 28: 910-915.
27. Remuzz I G., Sch Ieppat I A., Ruggenent I P. Clinical practice. Nephropathy in patients with type 2 diabetes. N. Engl. J. Med., 2002, 346: 1145-1151.